Summary
Isabel Woodford discusses how therapists and celebrities are experimenting with AI twins, including Sequoia-backed Delphi and bots trained on Claude or OpenAI. The segment contrasts direct patient-facing bots with therapist-mediated AI assistance, highlighting access, scalability, safety, liability, and monetization concerns. It notes that the American Sociological Association expects a hybrid human-AI therapy future and that the NHS already uses specialist mental-health chatbots. No public-market investment recommendations are made.
- Therapists and celebrities are creating AI twins that mimic their communication.
- Delphi is a Sequoia-backed startup enabling verified digital twins.
- Some therapists let bots interact directly; others use AI as an intermediary.
- A researcher predicts a hybrid future of human therapists plus AI support.
- The NHS already uses specialist mental-health chatbots.
- Safety tests show Delphi handles extreme crises but misses anxiety and obsessive thinking.
- Liability and monetization questions remain unresolved.
- The $50 billion therapy industry faces adoption and economic disruption.